Hypoxia and Potassium Channel Activity in T Lymphocytes
Hypoxia and Potassium Channel Activity in T Lymphocytes
批准号:
7729805
负责人:
LAURA CONFORTI
金额:
$30.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2013-04-30
关键词:
AdenosineAffectCalciumCell physiologyCellsCyclic AMP-Dependent Protein KinasesDataDevelopmentDiseaseDown-RegulationEngineeringEnvironmentFailureGoalsHumanHypoxiaImmuneImmune systemImmunologic SurveillanceIon ChannelKv1.3 potassium channelLaboratoriesMediatingMembraneOutcomeOxygenPlayPotassium ChannelProteinsPurinergic P1 ReceptorsReceptor ActivationRoleSignal PathwaySolid NeoplasmT memory cellT-Cell ProliferationT-LymphocyteTestingTherapeuticTumor-Infiltrating LymphocytesWorkbasecancer cellcancer typecell typecytokinedriving forcefightingimmune functioninsightlymphocyte proliferationnanoparticlenew therapeutic targetnovelnovel therapeuticsoutcome forecastpublic health relevancereceptorresearch studyresponsetargeted deliverytooltraffickingtumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A decrease in oxygen availability (hypoxia) can be encountered in solid tumors and has been associated with a poor outcome. Hypoxia can affect the function of many cells involved in tumor formation either directly or through the accumulation of adenosine. Both hypoxia and adenosine have been shown to inhibit the function of tumor infiltrating lymphocytes thus contributing to the failure of the immune system to fight cancer cells. The functionality of T lymphocytes relies on ion channels that control calcium (Ca2+) influx which is essential for the activation and function of these immune cells. Specifically two potassium channels, Kv1.3 and KCa3.1, play critical roles in the development and persistence of the Ca2+ response by regulating the driving force for Ca2+ influx. We have shown that hypoxia selectively inhibits the function and expression of Kv1.3 channels and decreases T cell proliferation and cytokine release. The mechanisms that mediate downregulation of Kv1.3 expression during hypoxia are not fully understood. Moreover, no information is available whether adenosine has any effect on these important channels and through them regulates T cell function. We have obtained preliminary evidence that adenosine inhibits the activity of KCa3.1 channels. Therefore, in the current application we will test the hypothesis that the microenvironment of solid tumors, and specifically hypoxia and adenosine, inhibit Kv1.3 and KCa3.1 channels producing a multidirectional attack on T cells that weakens the immune defense. We will perform experiments to identify the mechanisms that mediate downregulation of Kv1.3 expression in hypoxia. Furthermore, we will study the signaling pathways and functional relevance of KCa3.1 inhibition during hypoxia. We will also engineer multivalent nanoparticles to selectively target the expression of molecules involved in the decrease immune function by adenosine. Findings from the proposed studies will provide new insights into the mechanisms involved in decrease immune surveillance in solid tumors. Furthermore they will provide novel therapeutic targets and approaches to maintain the ability of immune cells to fight cancer cells in the hypoxic microenvironment. PUBLIC HEALTH RELEVANCE: One of the functions of the immune system is to attack cancer cells and destroy them. Unfortunately, there are special conditions in tumors that inhibit immune cell ability to do this. We propose to study how the effects of those conditions on ion channels in the membrane of immune cells contribute to the failure of the immune system to destroy cancer cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Liposome-based mRNA cancer immunotherapy targeting ion channels
-
批准号:10577013
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2022
-
负责人:LAURA CONFORTI
-
依托单位:
Targeted Ion Channel Downregulation By Nanoparticles: A Novel Therapeutic approa
-
批准号:8242217
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2011
-
负责人:LAURA CONFORTI
-
依托单位:
Targeted Ion Channel Downregulation By Nanoparticles: A Novel Therapeutic approa
-
批准号:8334424
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2011
-
负责人:LAURA CONFORTI
-
依托单位:
Potassium Channel Trafficking in Geometrically Patterned Immunological Synapses
-
批准号:7770863
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2009
-
负责人:LAURA CONFORTI
-
依托单位:
Potassium Channel Trafficking in Geometrically Patterned Immunological Synapses
-
批准号:7659936
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:6615927
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:7020672
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:7862521
-
项目类别:
-
资助金额:$31.91万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:7198061
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:8962319
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:8245787
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:9102972
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:8066466
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:6726855
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
Hypoxia and Potassium Channel Activity in T Lymphocytes
-
批准号:6879238
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2003
-
负责人:LAURA CONFORTI
-
依托单位:
海外基金